Oligometastatic Head and Neck Cancer: Challenges and Perspectives.

Simple Summary: Oligometastasis represents a disease state and an opportunity for cure when metastases emerge. Emerging evidence supports that most head and neck cancer patients with oligometastatic disease are likely to benefit from curative intent local ablative therapy if appropriate selection cr...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancers Vol. 14; no. 16; pp. 3894 - 3908
Autores principales: Bahig, Houda, Huang, Shao Hui, O'Sullivan, Brian
Formato: pictorial review tables/charts Journal Article
Publicado: MDPI Aug2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=158750462&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 158750462
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726694
        B74B
      jtl: Cancers
      issn: 20726694
      maglogo: N
    pubinfo:
      dt: Aug2022
      vid: 14
      iid: 16
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        158750462
        158750462
        158750462
        10.3390/cancers14163894
        158750462
      ppf: 3894
      ppct: 14
      formats:
      tig:
        atl: Oligometastatic Head and Neck Cancer: Challenges and Perspectives.
      aug:
        au:
          Bahig, Houda
          Huang, Shao Hui
          O'Sullivan, Brian
        affil: Department of Radiation Oncology, University of Montreal, Montreal, QC H2X 3E4, Canada
      sug:
        subj:
          Neoplasm Metastasis
          Head and Neck Neoplasms
          Neoplasm Metastasis Symptoms
          Head and Neck Neoplasms Symptoms
          Neoplasm Metastasis Drug Therapy
          Head and Neck Neoplasms Drug Therapy
          Neoplasm Metastasis Prognosis
          Head and Neck Neoplasms Prognosis
          Health Services Accessibility
          Needs Assessment
          Attitude to Illness
      ab: Simple Summary: Oligometastasis represents a disease state and an opportunity for cure when metastases emerge. Emerging evidence supports that most head and neck cancer patients with oligometastatic disease are likely to benefit from curative intent local ablative therapy if appropriate selection criteria are applied. Biomarkers to predict development of oligometastasis, as well as to identify which patients could benefit from a radical intent approach, are under investigation. This review summarizes recent knowledge about the characteristics, investigational efforts, and evidence for local ablation regarding oligometastasis in head and neck cancer. We also describe the challenges and opportunities in patient selection and discuss the role of radiotherapy and immunotherapy combinations to enhance anti-tumor immunity. A minority of patients with metastatic head and neck squamous cell carcinoma (HNSCC) present with oligometastatic disease. Oligometastasis not only reflects a disease state, but might also present an opportunity for cure in the metastatic setting. Radical ablation of all oligometastatic sites may confer prolonged survival and possibly achieve cure in some patients. However, substantial debate remains about whether patients with oligometastatic disease could benefit from curative intent therapy or whether aggressive treatments expose some patients to futile toxicity. Optimal selection of patients, carefully balancing the currently known prognostic factors against the risks of toxicity is critical. Emerging evidence suggests that patients with a limited burden of disease, viral-related pharyngeal cancer, metachronous metastasis and lung-only metastasis may benefit most from this approach. Efforts are underway to identify biomarkers that can detect oligometastasis and better select patients who would derive the maximum benefit from an aggressive radical approach. The combination of radiotherapy and immunotherapy promises to enhance the anti-tumoral immune response and help overcome resistance. However, optimization of management algorithms, including patient selection, radiation dose and sequencing, will be critical in upcoming clinical trials. This review summarizes recent knowledge about the characteristics and investigational efforts regarding oligometastasis in HNSCC.
      pubtype: Academic Journal
      doctype:
        pictorial
        review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N